Vital Importance of Biomedical Research – American Association for Cancer Research
American Association for Cancer Research shared a post on LinkedIn:
“Jennifer Ficko was diagnosed with stage IV melanoma in 2010.
For the next 7 years, she endured the severe side effects of a novel therapy while experiencing intermittent responses. By 2017, the treatment no longer kept her cancer in check, and she had few options left.
She enrolled in a clinical trial evaluating a novel immunotherapy pioneered at the NCI known as tumor-infiltrating lymphocyte (TIL) therapy. Jennifer had a severe reaction to the treatment and spent months in recovery, but she soon regained her strength, and she has been cancer free for nearly 8 years.
Jennifer’s story is a testament to the vital importance of biomedical research. But future progress against cancer is threatened by the President’s proposal to cut nearly 40% from the NIH budget.
Please support patients like Jennifer by calling on Congress to restore NIH investments in cancer research.”
Proceed to the video attached to the post.
More posts featuring American Association for Cancer Research.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023